What is in the Library of NCCN compendia?
The recommendations contained in the Library of NCCN Compendia are extracted directly from the relevant NCCN Guidelines to support clinical decision-making related to the use of drugs and biologics, biomarker testing, imaging and radiation therapy for patients with cancer.
Is the NCCN Compendium recognized by public and private insurers?
The NCCN Compendium is recognized by public and private insurers alike, including, but not limited to the Centers for Medicare and Medicaid Services (CMS) and UnitedHealthcare as an authoritative reference for oncology coverage policy.
Does NCCN make any warranties about the accuracy of its content?
NCCN DOES NOT WARRANT THE ACCURACY, APPROPRIATENESS, APPLICABILITY OR COMPLETENESS OF THE NCCN CONTENT, THE NCCN GUIDELINES OR ANY DERIVATIVE RESOURCES, NOR DOES NCCN MAKE ANY REPRESENTATIONS REGARDING THE USE OR RESULTS OF THE USE OF THE NCCN CONTENT, THE NCCN GUIDELINES OR ANY SUCH DERIVATIVE RESOURCES.
What is the NCCN imaging AUC™?
NCCN Imaging AUC™ include recommendations pertaining to cancer screening, diagnosis, staging, treatment response assessment, follow-up, and surveillance. NCCN is recognized by Centers for Medicare & Medicaid Services (CMS) as a qualified provider-led entity for creation of the NCCN Imaging AUC™ .
What is the NCCN compendia?
What is NCCN biomarker?
About this website
What is NCCN used for?
NCCN is a not-for-profit alliance of 32 leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives.
What is the meaning of NCCN?
National Comprehensive Cancer Network (NCCN) is an alliance of 32 cancer centers in the United States, most of which are designated by the National Cancer Institute (one of the U.S. National Institutes of Health) as comprehensive cancer centers.
What are NCCN Templates?
The NCCN Templates designate a specific order of administration if conclusive evidence is available to support a suggested chemotherapy sequence based on improved efficacy, decreased toxicity, or established clinical practice.
What are NCCN Guidelines?
The NCCN Guidelines are a comprehensive set of guidelines detailing the sequential management decisions and interventions that currently apply to 97 percent of cancers affecting patients in the United States.
Who funds the NCCN?
NCCN Foundation relies solely on donations and support from the community to fund our programs and services. Our supporters help change the lives of people with cancer and their families. Thank you for your generous support.
Where is NCCN?
NCCN's headquarters are located in Plymouth Meeting, PA, outside Philadelphia.
How do I get access to NCCN guidelines?
To use the NCCN Guidelines App, an individual must be a registered user on NCCN.org. There is no fee to become a registered user on NCCN.org and to view the NCCN Guidelines. Become a registered user (free) on NCCN.org. A new registration can be created from the welcome screen of the iPad and Google Play Apps as well.
Does Medicare follow NCCN guidelines?
Centers for Medicare and Medicaid Services (CMS) to officially recognize The NCCN Drugs and Biologics Compendium as a mandated reference for Medicare coverage decisions about the appropriate use of drugs and biologics in cancer care.
What is regimen in oncology?
Listen to pronunciation. (REH-jih-men) A treatment plan that specifies the dosage, the schedule, and the duration of treatment.
How important are NCCN Guidelines?
The NCCN Guidelines® currently apply to more than 97% of cancers affecting patients in the United States. The NCCN Guidelines incorporate real-time updates in keeping with the rapid advancements in the field of cancer research and management.
What is NCCN category?
The specific definitions of the NCCN categories for recommendations are: • Category 1: Based upon high-level evidence, there is uniform NCCN consensus that the intervention is appropriate; • Category 2A: Based upon lower-level evidence, there is uniform NCCN consensus that the intervention is appropriate; • Category 2B ...
What is NCCN score?
NCCN Evidence Blocks™ Development To develop the NCCN Evidence Blocks™, NCCN Panel members score each measure using a standardized scale from "1" to "5" with "1" being the least favorable and "5" the most favorable.
What is the full form of ESMO?
European Society for Medical Oncology.
What is the NCCN distress thermometer?
The NCCN Distress Thermometer and Problem List is a well-known screening tool among cancer care providers. It has been shown in many studies to work well. The Distress Thermometer measures distress on a 0 to 10 scale. To report your distress, circle the number that matches your level of distress in the past week.
NCCN Guidelines
When autocomplete results are available use up and down arrows to review and enter to select.
NCCN Chemotherapy Order Templates (NCCN Templates)
NCCN continues to add to the library of chemotherapy order templates to improve the safe use of drugs and biologics in cancer care. The information contained in the NCCN Templates ® is based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) and the NCCN Drugs & Biologics Compendium (NCCN Compendium ®).. NCCN Templates include:
COMPENDIA FOR COVERAGE OF OFF- LABEL USES OF DRUGS AND BIOLOGICS ... - CMS
Technology Assessment Technology Assessment Program Agency for Healthcare Research and Quality 540 Gaither Road Rockville, Maryland 20850 COMPENDIA FOR COVERAGE OF OFF-
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines Prostate ...
Updates in Version 3.2019 of the NCCN Guidelines for Prostate Cancer from Version 2.2019 include: PROS-14 • Systemic therapy for castration-naive disease:
Compendia 1861 (t)(2) - Anti-cancer | CMS
The Social Security Act Section 1861(t)(2)(B)(ii)(I) recognizes the following compendia: American Medical Association Drug Evaluations (AMA-DE), United States Pharmacopoeia-Drug Information (USP-DI) or its successor publication [amended in Section 6001 (f)(1) of the Deficit Reduction Act of 2005] and American Hospital Formulary Service-Drug Information (AHFS-DI) as authoritative sources for ...
What is the NCCN compendium?
The NCCN Compendium is a comprehensive listing of the drugs and biologics and the recommended uses for such agents in the treatment and management of patients with cancer. The NCCN Compendium is organized by and presented as an alphabetized index of drugs and biologics by generic name. The NCCN Compendium also has a multifactorial search function that allows searching by generic and brand names, histology, pharmacologic class, general indication, etc. Additionally, the NCCN Compendium includes a comprehensive summary of the pharmacologic characteristics of each drug and biologic by direct links from a specific agent in our electronic system to the up-to-date FDA labeled information. As such, information on clinical pharmacology, warnings, cautions, adverse events, drug interactions, dosing, schedule of administration, etc. is accessed by a single click on the link.
When studying the recommendations on a pathway, should the NCCN Guideline user be given information about how the recommendation was?
When studying the recommendations on a pathway, the NCCN Guideline user should be given information about how the recommendation was derived. In order to provide this critical information, the NCCN Guidelines Steering Committee has devised a set of Categories of Evidence and Consensus. These annotations contain two dimensions: the strength of the evidence behind the recommendation and the degree of consensus about its inclusion.
What is the NCCN compendia?
The recommendations contained in the Library of NCCN Compendia are extracted directly from the relevant NCCN Guidelines to support clinical decision-making related to the use of drugs and biologics, biomarker testing, imaging and radiation therapy for patients with cancer. NCCN Compendia are organized by disease type and are reviewed by members of the relevant NCCN panel before publication. NCCN Compendia are updated in conjunction with the NCCN Guidelines on a continual basis.
What is NCCN biomarker?
Contains information designed to support decision-making around the use of biomarker testing in patients with cancer. Tests that measure changes in genes or gene products and which are used for diagnosis, screening, monitoring, surveillance, or for providing predictive or prognostic information are included in the NCCN Biomarkers Compendium ® .
